{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:02:16Z","timestamp":1777518136220,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2023\/05739\\u20136"],"award-info":[{"award-number":["2023\/05739\\u20136"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2024\/05739\\u20136"],"award-info":[{"award-number":["2024\/05739\\u20136"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2024\/03928\\u20139"],"award-info":[{"award-number":["2024\/03928\\u20139"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2023\/14078\\u20133"],"award-info":[{"award-number":["2023\/14078\\u20133"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["302689\/2020\\u20136"],"award-info":[{"award-number":["302689\/2020\\u20136"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117858","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:07:12Z","timestamp":1750360032000},"page":"117858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Harnessing caseinolytic proteases ClpP1P2 for next-generation antimycobacterial agents: Mechanisms, challenges and opportunities"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8666-008X","authenticated-orcid":false,"given":"Andressa Franci\u00e9lli","family":"Bonjorno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateus Mello","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Lu\u00edsa","family":"Rodriguez Gini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cau\u00ea Benito","family":"Scarim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Leandro","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117858_bib1","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3390\/ijms20092232","article-title":"ClpP protease, a promising antimicrobial target","volume":"20","author":"Moreno-Cinos","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117858_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1146\/annurev-biochem-072711-164947","article-title":"Intrinsically disordered proteins and intrinsically disordered protein regions","volume":"83","author":"Oldfield","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2025.117858_bib3","doi-asserted-by":"crossref","first-page":"35424","DOI":"10.1074\/jbc.M507240200","article-title":"Human mitochondrial ClpP is a stable heptamer that assembles into a tetradecamer in the presence of ClpX","volume":"280","author":"Kang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib4","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.3390\/ijms22126228","article-title":"Mitochondrial caseinolytic protease P: a possible novel prognostic marker and therapeutic target in cancer","volume":"22","author":"Cormio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117858_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ceb.2016.02.001","article-title":"Regulators of mitochondrial dynamics in cancer","volume":"39","author":"Senft","year":"2016","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117858_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-physiol-021115-105011","article-title":"Mito-morphosis: Mitochondrial fusion, fission, and cristae remodeling as key mediators of cellular function","volume":"78","author":"Pernas","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejmech.2025.117858_bib7","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104705","article-title":"Molecular mechanisms and physiological functions of mitophagy","volume":"40","author":"Onishi","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.117858_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00746","article-title":"Bortezomib warhead-switch confers dual activity against mycobacterial caseinolytic protease and proteasome and selectivity against human proteasome","volume":"8","author":"Moreira","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117858_bib9","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.cell.2022.05.009","article-title":"BacPROTACs mediate targeted protein degradation in bacteria","volume":"185","author":"Morreale","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117858_bib10","first-page":"E4587","article-title":"Crystal structure of mycobacterium tuberculosis ClpP1p2 suggests a model for peptidase activation by aaa+ partner binding and substrate delivery","volume":"111","author":"Schmitza","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117858_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/mmi.12694","article-title":"Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase","volume":"93","author":"Schmitz","year":"2014","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117858_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1358539","article-title":"BacPROTACs targeting Clp protease: a promising strategy for anti-mycobacterial drug discovery","volume":"12","author":"Bonjorno","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib13","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.cell.2023.04.009","article-title":"Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival","volume":"186","author":"Hoi","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117858_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev-biochem-062917-012848","article-title":"Regulated proteolysis in bacteria","volume":"87","author":"Mahmoud","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2025.117858_bib15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/emboj.2012.5","article-title":"The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring","volume":"31","author":"Akopian","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.117858_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002511","article-title":"Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection","volume":"8","author":"Raju","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2025.117858_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-biochem-060408-172623","article-title":"AAA+ proteases: ATP-Fueled machines of protein destruction","volume":"80","author":"Sauer","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2025.117858_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbamcr.2011.06.007","article-title":"ClpXP, an ATP-powered unfolding and protein-degradation machine","volume":"1823","author":"Baker","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2025.117858_bib19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0076-6879(94)44027-1","article-title":"[25] ATP-dependent protease La (Lon) from Escherichia coli","author":"Goldberg","year":"1994","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.ejmech.2025.117858_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acschembio.9b00454","article-title":"Acyldepsipeptide antibiotics and a bioactive fragment thereof differentially perturb Mycobacterium tuberculosis ClpXP1P2 activity in vitro","volume":"18","author":"Schmitz","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117858_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature20122","article-title":"Arginine phosphorylation marks proteins for degradation by a Clp protease","volume":"539","author":"Trentini","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117858_bib22","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1074\/jbc.RA120.013456","article-title":"The unfoldase ClpC1 of mycobacterium tuberculosis regulates the expression of a distinct subset of proteins having intrinsically disordered termini","volume":"295","author":"Lunge","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib23","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1021\/cb400577b","article-title":"Antibacterial activity of and resistance to small molecule inhibitors of the clpp peptidase","volume":"8","author":"Compton","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117858_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1365-2958.2003.03524.x","article-title":"Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence","volume":"48","author":"Frees","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117858_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10295-015-1691-9","article-title":"Natural products as probes in pharmaceutical research","volume":"43","author":"Schmitt","year":"2016","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117858_bib26","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1128\/IAI.72.10.5646-5653.2004","article-title":"The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge","volume":"72","author":"Kwon","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2025.117858_bib27","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1046\/j.1365-2958.2000.01773.x","article-title":"The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes","volume":"35","author":"Gaillot","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117858_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/emmm.200900002","article-title":"The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease","volume":"1","author":"Kirstein","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117858_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nsmb.1787","article-title":"Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism","volume":"17","author":"Lee","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117858_bib30","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1002\/anie.201101740","article-title":"The natural product Cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease","volume":"50","author":"Schmitt","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117858_bib31","article-title":"The essential M. tuberculosis clp protease is functionally asymmetric in vivo","volume":"8","author":"d'Andrea","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.117858_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125345","article-title":"The Mycobacterium tuberculosis ClpP1P2 protease interacts asymmetrically with its ATPase partners ClpX and ClpC1","volume":"10","author":"Leodolter","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117858_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060228","article-title":"Mycobacterium tuberculosis ClpP proteases are Co-transcribed but exhibit different substrate specificities","volume":"8","author":"Personne","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117858_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53736-8","article-title":"Molecular and structural insights into an asymmetric proteolytic complex (ClpP1P2) from Mycobacterium smegmatis","volume":"9","author":"Nagpal","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117858_bib35","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1073\/pnas.1921630117","article-title":"An allosteric switch regulates Mycobacterium tuberculosis ClpP1P2 protease function as established by cryo-EM and methyl-TROSY NMR","volume":"117","author":"Vahidi","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.117858_bib36","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1074\/jbc.M115.700344","article-title":"Structure and functional properties of the active form of the proteolytic complex, ClpP1P2, from Mycobacterium tuberculosis","volume":"291","author":"Li","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/JB.06142-11","article-title":"Validation of the essential ClpP protease in Mycobacterium tuberculosis as a novel drug target","volume":"194","author":"Ollinger","year":"2012","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejmech.2025.117858_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/mmi.13362","article-title":"Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease","volume":"101","author":"Famulla","year":"2016","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117858_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","article-title":"Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2","volume":"21","author":"Gavrish","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117858_bib40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/AAC.04054-14","article-title":"The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117858_bib41","doi-asserted-by":"crossref","first-page":"30883","DOI":"10.1074\/jbc.M113.493767","article-title":"Structural basis of mycobacterial inhibition by cyclomarin A","volume":"288","author":"Vasudevan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib42","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.1074\/jbc.RA118.002251","article-title":"The antibiotic cyclomarin blocks arginine-phosphate\u2013induced millisecond dynamics in the N-terminal domain of ClpC1 from Mycobacterium tuberculosis","volume":"293","author":"Weinh\u00e4upl","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-04658-9","article-title":"ClpC2 protects mycobacteria against a natural antibiotic targeting ClpC1-dependent protein degradation","volume":"6","author":"Taylor","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2025.117858_bib44","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1074\/jbc.M114.625640","article-title":"Cleavage specificity of Mycobacterium tuberculosis ClpP1P2 protease and identification of novel peptide substrates and boronate inhibitors with anti-bacterial activity","volume":"290","author":"Akopian","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00253-15","article-title":"Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria","volume":"6","author":"Moreira","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2025.117858_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00338-16","article-title":"Mycobacterial caseinolytic protease gene regulator ClgR is a substrate of caseinolytic protease","volume":"2","author":"Yamada","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.ejmech.2025.117858_bib47","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1038\/s41467-025-58410-4","article-title":"Structural insights into bortezomib-induced activation of the caseinolytic chaperone-protease system in Mycobacterium tuberculosis","volume":"16","author":"Zhou","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117858_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02307-16","article-title":"Towards selective mycobacterial ClpP1P2 inhibitors with reduced activity against the human proteasome","volume":"61","author":"Moreira","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117858_bib49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bioorg.2018.06.004","article-title":"Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis","volume":"80","author":"Liu","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib50","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1021\/acs.jmedchem.3c01054","article-title":"Discovery and mechanistic study of novel Mycobacterium tuberculosis ClpP1P2 inhibitors","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117858_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/mlf2.12169","article-title":"Identification of a phenyl ester covalent inhibitor of caseinolytic protease and analysis of the ClpP1P2 inhibition in mycobacteria","volume":"4","author":"Xiao","year":"2025","journal-title":"MLife"},{"key":"10.1016\/j.ejmech.2025.117858_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202100270","article-title":"Recent developments in PROTAC\u2010Mediated protein degradation: from bench to clinic","volume":"23","author":"Hu","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.117858_bib53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbamcr.2013.06.031","article-title":"Protein quality control and elimination of protein waste: the role of the ubiquitin\u2013proteasome system","volume":"1843","author":"Amm","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2025.117858_bib54","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/s41467-024-46218-7","article-title":"Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria","volume":"15","author":"Junk","year":"2024","journal-title":"Nat. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:13:17Z","timestamp":1762265597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":54,"alternative-id":["S0223523425006233"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117858","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing caseinolytic proteases ClpP1P2 for next-generation antimycobacterial agents: Mechanisms, challenges and opportunities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117858"}}